NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Aug 20 2025

· Issued by NATCO Pharma Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-20-2025-4

Natco Pharma Limited has informed the Exchange regarding a press release dated August 20, 2025, titled "NATCO launches Bosentan Tablets for Oral Suspension (generic of Tracleer®) in the United States with 180-day exclusivity".

View Attachment

6ix hasn’t read this filing yet.

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases